CFP: Evidence-Based Medicine Reconsidered

Submission deadline: November 17, 2024

Conference date(s):
April 5, 2025 - April 6, 2025

Go to the conference's page

Conference Venue:

The Center for Philosophy of Science, University of Pittsburgh
Pittsburgh, United States

Details

Evidence-Based Medicine Reconsidered

April 5, 2025 @ 8:00 am - April 6, 2025 @ 5:00 pm EDT

Senior Visiting Fellow Conference by Carl Hoefer

The evidence-based medicine (EBM) movement began in the 1980s, reached its peak perhaps in the 1990s, and has since then enjoyed the status of orthodoxy, despite many criticisms being raised among medical practitioners and researchers. Philosophers of medicine have frequently criticized EBM’s hierarchies and rigid precepts, especially the “gold standard” status of randomized controlled trials (RCTs). A pluralistic approach to evidence in medicine has been increasingly popular in recent years, in which mechanistic evidence and reasoning, observational studies of many kinds and RCTs are assessed for value on a case-by-case basis. But does this trend away from the EBM hierarchy go too far and risk the reintroduction of the same biased, motivated evidence-gathering practices that originally motivated the EBM movement? What light can recent experiences in medicine and public health (e.g., during the covid-19 pandemic) shed on these issues?

Call for Abstracts

We invite papers which address topics related to evidence in medicine, broadly speaking. These include, but are not limited to:

  • Defenses (or criticisms) of the supposed superiority of RCTs over observational studies, mechanistic studies, modeling, and individual clinical judgment;
  • Discussions of lessons that philosophy of medicine or EBM can learn from recent experiences;
  • Papers offering theoretical discussions of procedures for integrating and evaluating evidence from different sources;
  • The merits and limitations of emerging kinds of medical evidence, such as adaptive trials, so-called real-world evidence, precision or personalized medicine research, and big data research
  • Evidence in diverse contexts, such as clinical practice, alternative healthcare, drug or device regulation, public health, and health policy.

Abstracts should be between 500-800 words long and should be sent by November 17th to: [email protected]

Supporting material

Add supporting material (slides, programs, etc.)